In depth
Sjogren's disease and exercise
Six randomized trials exist in the whole of this condition, and that is the entire evidence base. They agree that fitness improves and they don't show that disease activity changes, and both halves of that are worth having. What follows says which findings come from Sjogren's trials and what those trials were.
What the research found.
Pooling the entire randomized exercise literature in Sjogren's disease gives 6 trials and 277 participants between them. Standardized mean differences came out at 0.69 for functional capacity, 0.59 for cardiopulmonary function, 0.51 for vitality, and 0.46 for general health status. Those are moderate effects on the things exercise usually moves.
In that same pooled analysis, the effect on disease activity measured by ESSDAI came out at negative 0.09. Its confidence interval ranged from negative 0.41 to 0.23. The effects on pain and fatigue didn't reach significance either, so the disease score is the thing exercise leaves alone.
In 60 women randomized to supervised training twice weekly, peak oxygen uptake rose from 19.64 to 22.95 mL per kilogram per minute. The control group fell from 21.96 to 20.20 over the same period. The between-group difference came at a P value below 0.001, which is the clearest fitness result in this literature.
In 45 sedentary women randomized to supervised walking three times weekly for 16 weeks, peak oxygen uptake, walking distance, and fatigue all favored the training group. Global improvement was reported by 95.4 percent of them. Among the controls it was 62 percent, and no disease flares or serious adverse events were reported.
The entire literature is six trials
Everything known from randomized trials about exercise in Sjogren's disease comes from 6 studies and 277 people, with 141 in intervention groups and 136 in control groups. Those trials tested aerobic training, resistance training, supervised walking, and pelvic floor and diaphragm exercises between them. That's the whole field.
The size counts for how you read anything that follows. A pooled estimate built on 277 people across six different programs involves real uncertainty, and the authors of the pooled analysis downgraded their own certainty ratings for just that reason. Their assessments ranged from moderate down to very low depending on the outcome.
It also explains why advice about exercising with Sjogren's tends to be vague. There isn't a tested program to point at, and most of what gets recommended is borrowed from other conditions without saying so. This page says which findings come from Sjogren's trials and what they were.
Fitness and function improve
The clearest results are on the outcomes exercise usually moves. Pooled standardized mean differences were 0.69 for functional capacity, 0.59 for cardiopulmonary function, 0.51 for vitality, 0.46 for general health status, and 0.42 for mental health. Certainty was rated moderate for functional capacity and vitality, and low for cardiopulmonary function, general health, and mental health.
Individual trials put numbers on what that means in practice. In 60 women randomized to supervised training twice weekly, peak oxygen uptake rose from 19.64 to 22.95 milliliters per kilogram per minute. The control group fell from 21.96 to 20.20 over the same period, and two thirds of the exercise group gained 15 percent or more. Their anaerobic threshold rose as well and their HbA1c fell slightly.
A separate trial randomized 45 sedentary women to supervised walking three times weekly for 16 weeks. Peak oxygen uptake, walking distance, and fatigue all favored the training group, and 95.4 percent of them reported global improvement against 62 percent of controls. No disease flares and no serious adverse events were reported.
Disease activity doesn't move
The pooled effect on the EULAR disease activity index was negative 0.09, with a confidence interval from negative 0.41 to 0.23. That's no effect, and it came with moderate certainty, which makes it one of the more dependable findings in the set. The trial of 60 women reached the same place independently, finding no between-group difference in disease activity or quality of life despite a clear difference in fitness.
Pain and fatigue are in between. Pain pooled at 0.32 with a confidence interval from negative 0.09 to 0.72, which crosses zero, and its certainty was rated very low. Fatigue pooled at negative 0.57 with an interval from negative 1.57 to 0.44 and heterogeneity of 85 percent, so the trials disagreed with each other substantially.
Individual trials are friendlier on fatigue than the pooled figure. A narrative review of 5 studies found fatigue improved more than control in all three studies that measured it, and the walking trial found a significant benefit. Reporting both readings is the honest thing to do, and the pooled one is the more cautious.
Why within-group improvement isn't the same as benefit
The narrative review of 5 studies and 244 women found a repeating form. Significant within-group improvements were common, and between-group superiority was rare. Four studies showed quality of life improving within the exercise group and only one showed it beating the control group.
That happens because control groups improve too, through attention, expectation, and the ordinary variation of a fluctuating disease. It's the reason a personal improvement over 12 weeks, however real it feels, doesn't establish what caused it. The pooled analysis exists to get past that, and it's why its numbers are more conservative than any single trial's before and after figures.
The same review recorded the safety information worth having. There were 28 dropouts in total, 14 of them from exercise groups, and 5 adverse events made up of one episode of chest pain and four of joint pain. That's a reassuring overall picture with two things in it worth mentioning to whoever supervises you.
What to do with all this
Exercise in Sjogren's disease is worth doing for the same reasons anybody exercises, with a measurable gain in fitness and function on top. The trials that exist ran supervised programs two or three times a week in sessions of 30 to 60 minutes over 12 to 28 weeks, and one resistance program used 3 sets of 10 repetitions at 60 to 80 percent of a single repetition maximum. Those figures describe what has been tested rather than what's best, because doses have never been compared here.
What to expect counts as much as what to do. Fitness, walking distance, vitality, and general health are the outcomes with support behind them. A lower disease activity score isn't, and going in expecting one is how a reasonable program ends up feeling like a failure.
Dryness deserves its own thought before you start. Reduced saliva and tears make exertion less comfortable, particularly in wind or air conditioning, and taking water with you counts more when the problem is production rather than thirst. Not one of those appears in the trials, and all of it is worth planning for.
Common misconceptions.
Myth. Exercise will bring my Sjogren's disease activity down.
Reality. The pooled effect on disease activity across the whole randomized literature was negative 0.09, with a confidence interval from negative 0.41 to 0.23. That's no effect, and the certainty on that particular finding was rated moderate, which makes it one of the more reliable numbers in the set. Exercise is worth doing here for fitness, fatigue, and function, and not for the disease score.
Myth. There's a body of research telling me what to do.
Reality. There are 6 randomized trials and 277 people in total. That's the entire randomized exercise literature in this condition, and it covers aerobic training, resistance training, walking, and pelvic floor work between them. Any confident prescription for Sjogren's specifically is drawing on more than exists.
Myth. Exercise is completely without risk in Sjogren's.
Reality. Nothing here suggests serious harm and the reporting isn't silent either. A narrative review of 5 studies recorded 28 dropouts, 14 of them from exercise groups, and 5 adverse events, being one episode of chest pain and four of joint pain. Two trials reported no disease flares and no serious adverse events at all. That's a reassuring picture with a caveat attached rather than a spotless one.
Myth. If I feel better on a program, the program worked.
Reality. Across 5 studies, significant within-group improvement was common and between-group superiority was rare, meaning the control groups often improved too. That's why the pooled analysis counts more than any single trial's before and after figures. It's also why a personal improvement over 12 weeks, however real it feels to you, isn't proof of what caused it.
Cautions specific to this condition.
- Ask about dryness during exercise, because reduced saliva and tears make exertion, wind, and air conditioning less comfortable than they are for other people.
- Take water with you and expect to need it more often than the person next to you, since the problem is production and not thirst.
- Get chest pain assessed. Don't push through it, because one of the five recorded adverse events across these trials was chest pain.
- Mention any joint pain that starts with a new program, since four of the five recorded adverse events were joint pain and adjusting the program is usually enough.
- Tell whoever supervises you that this is Sjogren's disease, because the trials that exist ran supervised programs twice or three times weekly at 30 to 60 minutes.
- Take new breathlessness, numbness, or tingling to your rheumatology team, because Sjogren's can involve the lungs, kidneys, and nerves.
Discuss any change with the rheumatologist who manages your care. Nothing here replaces that conversation.
Questions patients ask.
How much research is there on exercise in Sjogren's?
Six randomized trials and 277 participants in total, which is the entire randomized literature in this condition. They tested aerobic training, resistance training, supervised walking, and pelvic floor and diaphragm work between them, which is a lot of ground for six studies to cover. For comparison, a single moderate trial in rheumatoid arthritis often enrolls more people than that. Everything on this page comes from a body of work that small.
What does exercise improve?
Fitness and function most clearly. The pooled standardized mean differences were 0.69 for functional capacity, 0.59 for cardiopulmonary function, 0.51 for vitality, and 0.46 for general health status, with mental health at 0.42. Certainty was rated moderate for functional capacity and vitality and low for the others. Those are moderate effects on the things exercise usually moves rather than a surprise.
Will it help my fatigue?
The pooled figure didn't reach significance, at negative 0.57 with a confidence interval ranging from negative 1.57 to 0.44 and heterogeneity of 85 percent. Individual trials tell a friendlier story, with fatigue improving more than control in all three studies that measured it in one review, and a walking trial reporting a significant fatigue benefit. The pooled result is the more conservative reading and both are honest.
Does it change my disease activity?
No, on the evidence available. The pooled effect on the EULAR disease activity index was negative 0.09 with a confidence interval from negative 0.41 to 0.23, which is no effect, and that finding came with moderate certainty. One trial of 60 women likewise found no between-group difference on disease activity or on quality of life, despite a clear difference in fitness. Exercise isn't a disease-modifying treatment here.
What did the trials have people do?
Supervised programs, two or three times a week, in sessions of 30 to 60 minutes, running 12 to 28 weeks. One resistance trial used 3 sets of 10 repetitions at 60 to 80 percent of a single repetition maximum over 16 weeks. A walking trial ran three times weekly for 16 weeks. Those parameters describe what has been tested rather than what's optimal, because doses have never been compared in this condition.
Is it safe?
The evidence is reassuring and it isn't silent about problems. Two trials reported no disease flares and no serious adverse events. A separate review of 5 studies recorded 5 adverse events, one of chest pain and four of joint pain, and noted that 14 of 28 total dropouts came from exercise groups. That's worth knowing, because a symptom you assume can't happen never gets raised.
Should I bother, if it doesn't touch the disease?
The reasons for exercising in Sjogren's are the same reasons everybody else has, plus a measurable gain in fitness and function in the trials that exist. Cardiovascular risk, bone strength, and independence all matter and no disease activity index counts any of them. Expecting a lower disease score is the part likely to disappoint, and expecting to walk further with less effort isn't.
References.
- Gao Q; Fan C; Zhang Y et al. Effects of physical activity on health-related outcomes in Sjögren’s syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology. 2026;17. 10.3389/fimmu.2026.1753791Systematic review and meta-analysis of RCTs
- Ayán-Pérez C; Carballo-Afonso R; Bueno-Russo R et al. Is Physical Exercise Beneficial for People with Primary Sjögren’s Syndrome? Findings from a Systematic Review. Applied Sciences. 2025;15:1455. 10.3390/app15031455Systematic review
- Garcia A; Dardin L; Minali P et al. Cardiovascular Effect of Physical Exercise on Primary Sjogren's Syndrome (pSS): Randomized Trial. Frontiers in Medicine. 2021;8. 10.3389/fmed.2021.719592Randomised controlled trial
- Miyamoto S; Valim V; Carletti L et al. Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trial. Rheumatology International. 2019;39:227-238. 10.1007/s00296-018-4213-zRandomised controlled trial
- Dardin L; Garcia A; Minali P et al. The effects of resistance training in patients with primary Sjogren’s syndrome. Clinical Rheumatology. 2021;41:1145-1152. 10.1007/s10067-021-05977-0Parallel
- Strombeck B; Theander E; Jacobsson L. Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome. Rheumatology. 2007;46:868-871. 10.1093/rheumatology/kem004Randomised controlled trial of aerobic
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.